Systemic inflammation with a gut component: KPV is the primary choice
10.1097/00075197-200107000-00006 60 CarN.SkrabaloZ.VerhoM
In addition to retatrutide, a growing pipeline of emerging compounds includes other multi-agonists such as Survodutide (GLP-1/glucagon co-agonist), and Cagrilintide (a long-acting amylin analogue), all currently being evaluated in advanced clinical trials (139)
For individuals focusing on antioxidant support from high oxidative stress, it may be beneficial to adjust these dosages, but it's essential to consult with a healthcare professional for personalized advice
Gross necropsy and histopathologic examination of animals receiving high-dose BPC-157 found no organ damage in liver, spleen, lung, kidney, brain, thymus, prostate, ovaries, or gastric wall